Prostate cancer is the most common solid tumor, with approximately 200,000 new cases diagnosed each year. Several different therapies are available for treatment including surgery, radiotherapy and radiation therapy. The Winship Cancer Institute of Emory University prostate cancer program offers cutting-edge treatment, such as high dose rate brachytherapy for newly diagnosed and recurrent prostate cancer patients.

Our approach to patient care is collaborative, multi-disciplined and we understand that each patient’s situation is unique. Emory Healthcare works with you so that you can make informed decisions when choosing prostate cancer treatment.

Select and option below to learn more.

I’ve been newly diagnosed with prostate cancer

more-info-button-2.2

I’d like information on recurrent prostate cancer

more-info-button-2.2

Men’s health treatment & screening information

more-info-button-2.2


Clinical trial for recurrent prostate cancer

As a National Cancer Institute (NCI) designated cancer center, Winship Cancer Institute of Emory University’s participation in clinical trials ensures our prostate patients have access to progressive resources and technology. For men with recurrent prostate cancer, there are newer methods of imaging such as magnetic resonance imaging (MRI) and positron emission tomography (PET). Learn more >>


Have questions? Emory HealthConnection℠ is a direct line to registered nurses and representatives who may be able to answer your health related questions. Plus, they can help you plan a visit to any Emory Healthcare location. Call (404) 778-0497, Mon-Fri 7:30 a.m. to 6 p.m. EST.